PlainRecalls
ModerateActive

CPSC recall · Reported January 14, 2021

Scalpa Recalls Scalpa Numb Maximum Strength Topical Anesthetic Cream Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

The product contains the substance lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is …

Recall #
21719
Affected scope
About 10,000
Verify with CPSC →
View my saved recalls

Scalpa Inc., of Phoenix, Ariz. recalled This recall involves Scalpa Numb Maxium Strength Topical Anesthestic Cream in a 10 gram b… - a moderate-severity action.

Scalpa Recalls Scalpa Numb Maximum Strength Topical Anesthetic Cream Due to Failure to Me… was recalled by Scalpa Inc., of Phoenix, Ariz. in January 14, 2021. Reason: The product contains the substance lidocaine which must be in child resistant packaging as required by the Po…. Remedy: Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a sa…. Verify recall #21719 with the CPSC before acting.

The recall

Scalpa Inc., of Phoenix, Ariz. issued this moderate-severity CPSC recall-The product contains the substance lidocaine which must be in child resistant packaging as required by the Po….

Moderate
severity level
January 14, 2021
reported

Sourced from official CPSC enforcement records. Verify recall #21719 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This CPSC action (record #21719) was formally reported on January 14, 2021. It is classified under Moderate severity, with a current status of Active. Scalpa Inc., of Phoenix, Ariz. is listed as the recalling firm. Federal records list the affected scope as About 10,000.

The documented reason for this recall is: The product contains the substance lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant, posing a risk of po… Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a safe location out of reach of children and contact Scalpa for a full refund or store credit. Scalpa is directly … - consumers holding this product should act on that instruction rather than relying on general guidance.

Within the same product category the archive holds 6 closely related recalls, 6 from CPSC - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Children & Baby Products recalls over time

Where this recall sits in its category - 3,731 children & baby products recalls on record

0100200300400500600 20052008201120142017202020232026 146
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

About 10,000

Related Recalls

6

6 from same agency

Product description

This recall involves Scalpa Numb Maxium Strength Topical Anesthestic Cream in a 10 gram black and white tube with a white cap. "SCALPANUMB" and "Maximum Strength Topical Anesthetic Cream" are printed on the label. The expiration date is marked as EXP 202307 on the crimped end of the tube. Batch number 1000000101, Code: C1 and the UPC code 857076008689 are printed on the outside of the box.

Reason for recall

The product contains the substance lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant, posing a risk of poisoning to young children.

Remedy, what to do

Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a safe location out of reach of children and contact Scalpa for a full refund or store credit. Scalpa is directly notifying all known purchasers about the recall.

Recall Profile

Structured summary of the CPSC recall record
Attribute Value
Agency U.S. Consumer Product Safety Commission
Severity class Moderate
Status Active
Recall number 21719
Date reported January 14, 2021
Date initiated January 14, 2021
Recalling firm Scalpa Inc., of Phoenix, Ariz.
Affected scope About 10,000
Distribution Not disclosed
Official source CPSC notice →

Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.

What to do with this recall

Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a safe location out of reach of children and…

  • Check the recall number (21719) and product description against the item you own. Search the archive
  • Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
This recall involves Scalpa Numb Maxium Strength Topical Anesthestic Cream in a 10 gram black and white tube with a white cap. "SCALPANUMB" and "Maximum Strength Topical Anesthetic Cream" are printed on the label. The expiration date is marked as EXP 202307 on the crimped end of the tube. Batch number 1000000101, Code: C1 and the UPC code 857076008689 are printed on the outside of the box.. Recalled by Scalpa Inc., of Phoenix, Ariz.. Units affected: About 10,000.
Why was this product recalled?
The product contains the substance lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant, posing a risk of poisoning to young children.
What should consumers do?
Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a safe location out of reach of children and contact Scalpa for a full refund or store credit. Scalpa is directly notifying all known purchasers about the recall.
Which agency issued this recall?
This recall was issued by the CPSC on January 14, 2021. Severity: Moderate. Recall number: 21719.
How do I check if my product is affected by a recall?
Check the product description and recall number (21719) against your product. Visit the official CPSC website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
How do I report an injury from a recalled product?
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →

Browse all Children & Baby Products recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: CPSC, reported January 14, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.